News

Modern veterinary vaccine manufacturing technologies rely on innovative techniques such as DNA vaccines, mRNA vaccines, and

Recombinant Vaccines.

In contrast, quality controls focus on rigorous verification processes, compliance with Good Manufacturing Practices (GMP), and ensuring the safety, stability, and potency of the vaccine until it reaches the animal.

• DNA and mRNA Vaccines: These technologies use genetic blueprints to produce antigens instead of the antigens themselves, allowing for the stimulation of a stronger and more sustained immune response.
• Recombinant Vaccines: These allow for the design of versatile vaccines that can target multiple viral strains using different genes.
• Live Attenuated Vaccines: While still common in the veterinary sector, genetic engineering techniques enhance their effectiveness and increase their safety, allowing them to respond better against different viral strains.
• Vaccination using radiation technology: Radiation can be used to inactivate microorganisms to produce safer vaccines, as this method preserves the organism's structure and allows the immune system to recognize it.

• Verification processes: The manufacturing process must be validated to ensure it yields a consistent final product.
• Good Manufacturing Practices (GMP): All vaccines must be manufactured according to these practices to ensure quality and safety.
• Antigen safety verification: Antigens must be evaluated to ensure their safety and suitability for use in animals.
• Studies: Studies must be conducted to evaluate the stability of new vaccines and determine their expiration dates. Its validity.
•  
• Identification of impurities: Impurities must be identified, described, and their integrity verified according to VICH guidelines.